» Articles » PMID: 16563567

Altered Expression of Vesicular Glutamate Transporters VGLUT1 and VGLUT2 in Parkinson Disease

Overview
Journal Neurobiol Aging
Publisher Elsevier
Date 2006 Mar 28
PMID 16563567
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Glutamatergic pathways play a key role in the functional organization of neuronal circuits involved in Parkinson disease (PD). Recently, three vesicular glutamate transporters (VGLUT1-3) were identified. VGLUT1 and VGLUT2 are responsible for the uploading of glutamate into synaptic vesicles and are the first specific markers of glutamatergic neurons available. Here, we analyzed the expression of VGLUT1 and VGLUT2 in autopsy tissues of PD patients and matched controls using Western blot and immunoautoradiography. VGLUT1 and VGLUT2 expression was increased in the Parkinsonian putamen by 24% and 29%, respectively (p<0.01). In contrast, only VGLUT1 was dramatically decreased in the prefrontal and temporal cortex of PD patients (approximately 50%, p<0.01 and p<0.001, respectively). These findings demonstrate the existence of profound alterations of glutamatergic transmission in PD, which are likely to contribute to the motor and cognitive impairments associated with the disease, and should thus be taken into account in the treatment of PD.

Citing Articles

Control of Dopamine Signal in High-Order Receptor Complex on Striatal Astrocytes.

Amato S, Averna M, Farsetti E, Guidolin D, Pedrazzi M, Gatta E Int J Mol Sci. 2024; 25(16).

PMID: 39201299 PMC: 11354247. DOI: 10.3390/ijms25168610.


Effects of Paraquat, Dextran Sulfate Sodium, and Irradiation on Behavioral and Cognitive Performance and the Gut Microbiome in A53T and A53T-L444P Mice.

Chaklai A, ONeil A, Goel S, Margolies N, Krenik D, Perez R Genes (Basel). 2024; 15(3).

PMID: 38540341 PMC: 11154584. DOI: 10.3390/genes15030282.


Morphological changes in perisynaptic astrocytes induced by dopamine neuronal degeneration in the striatum of rats.

Sun L, Zheng X, Che Y, Zhang Y, Huang Z, Jia L Heliyon. 2024; 10(6):e27637.

PMID: 38510046 PMC: 10950654. DOI: 10.1016/j.heliyon.2024.e27637.


Amino Acid Transporters Proteins Involved in the Glutamate-Glutamine Cycle and Their Alterations in Murine Models of Alzheimer's Disease.

Vazquez-Duran D, Ortega A, Rodriguez A Mol Neurobiol. 2024; 61(8):6077-6088.

PMID: 38273046 DOI: 10.1007/s12035-024-03966-3.


Simulated vestibular spatial disorientation mouse model under coupled rotation revealing potential involvement of Slc17a6.

Chang T, Zhang M, Zhu J, Wang H, Li C, Wu K iScience. 2024; 26(12):108498.

PMID: 38162025 PMC: 10757040. DOI: 10.1016/j.isci.2023.108498.


References
1.
Lange K, Kornhuber J, Riederer P . Dopamine/glutamate interactions in Parkinson's disease. Neurosci Biobehav Rev. 1997; 21(4):393-400. DOI: 10.1016/s0149-7634(96)00043-7. View

2.
Anglade P, Mouatt-Prigent A, Agid Y, Hirsch E . Synaptic plasticity in the caudate nucleus of patients with Parkinson's disease. Neurodegeneration. 1996; 5(2):121-8. DOI: 10.1006/neur.1996.0018. View

3.
Sidibe M, Smith Y . Thalamic inputs to striatal interneurons in monkeys: synaptic organization and co-localization of calcium binding proteins. Neuroscience. 1999; 89(4):1189-208. DOI: 10.1016/s0306-4522(98)00367-4. View

4.
Imon Y, Matsuda H, Ogawa M, Kogure D, Sunohara N . SPECT image analysis using statistical parametric mapping in patients with Parkinson's disease. J Nucl Med. 1999; 40(10):1583-9. View

5.
Daniels R, Collins C, Gelfand M, Dant J, Brooks E, Krantz D . Increased expression of the Drosophila vesicular glutamate transporter leads to excess glutamate release and a compensatory decrease in quantal content. J Neurosci. 2004; 24(46):10466-74. PMC: 6730318. DOI: 10.1523/JNEUROSCI.3001-04.2004. View